Studies Point to Several Options for Ulcerative Colitis After Anti-TNF Failure

(MedPage Today) — SAN FRANCISCO — Research presented at the annual Crohn’s and Colitis Congress included studies comparing the effectiveness of vedolizumab (Entyvio) versus ustekinumab (Stelara) and of each biologic against Janus kinase (JAK…

Source link : https://www.medpagetoday.com/meetingcoverage/ccc/114186

Author :

Publish date : 2025-02-12 15:45:58

Copyright for syndicated content belongs to the linked Source.